Skip to main content
HANDOK Inc. logo

HANDOK Inc. — Investor Relations & Filings

Ticker · 002390 ISIN · KR7002390003 KO Manufacturing
Open in API
Filings indexed 422 across all filing types
Latest filing 2025-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 002390

About HANDOK Inc.

https://www.handok.co.kr/en/

Handok Inc. is a total healthcare company that develops, manufactures, and distributes a comprehensive range of healthcare solutions. Its portfolio includes prescription drugs, general medicine, medical devices, and in-vitro diagnostics. The company's core business focuses on therapeutic areas such as diabetes, cardiovascular and musculoskeletal diseases, and psychoneurotic disorders, in addition to human vaccines. Positioning itself as a "Health Innovator," Handok provides products and services aimed at prevention, diagnosis, and health management. The company collaborates with global enterprises and manages the entire value chain from sourcing and development to commercialization.

Recent filings

Filing Released Lang Actions
[기재정정]분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Handok' (주식회사 한독) for the period ending March 31, 2025. It contains detailed financial statements, notes to the financial statements, and management information. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-15 Korean
합병등종료보고서(분할)
M&A Activity Classification · 100% confidence The document is a 'Report on the Completion of Merger/Division' (합병등종료보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details the finalization of a corporate division (split-off) process, including the timeline, shareholder appraisal rights, and post-division financial information. Since this is a formal regulatory filing regarding corporate restructuring (M&A/Division) and does not fit into the specific categories of 'M&A Activity' (which usually refers to the proposal/announcement phase) or 'Annual Report', it is classified as a Regulatory Filing.
2025-05-13 Korean
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (Handok) regarding the adjustment of the conversion price of convertible bonds due to a decline in market price. This type of disclosure is a standard corporate action related to capital structure and financing instruments. Since it specifically details the adjustment of conversion prices for convertible securities, it falls under the 'Capital/Financing Update' category.
2025-05-13 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to employees, including the number of shares, exercise price, and legal basis. This type of disclosure regarding capital structure changes and equity-based compensation is classified as a Regulatory Filing (RNS) in the absence of a more specific category for stock option grants.
2025-05-12 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from Handok Inc. regarding the 'Decision to Dispose of Treasury Shares' (자기주식 처분 결정). It details the number of shares to be disposed of, the disposal method, and the purpose. According to the provided definitions, reports regarding a company buying back or selling its own shares are classified as 'Transaction in Own Shares' (POS).
2025-05-12 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically marked as a '정정신고' (Amendment Report). It details changes to previously reported stock option grants, including adjustments to the number of recipients and the total number of shares. This type of disclosure regarding stock option grants and their subsequent amendments is a standard regulatory requirement for listed companies, falling under the category of general regulatory filings.
2025-05-12 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.